; and (2) $3,000,000 for the period of fiscal years 2026 through 2028. 4. Coordinating Committee on Research Specific to Pregnant and Lactating Women (a) Establishment Not later than 90 days after the date of enactment of this Act, the Secretary shall establish a committee, in accordance with the Federal Advisory Committee Act (5 U.S.C. App.), to be known as the Committee on Research Specific to Pregnant and Lactating Women or the PRGLAC Committee (in this section referred to as the Committee ) to advise on coordinating Federal activities to address gaps in knowledge and research regarding safe and effective therapies for pregnant and lactating women. (b) Duties The Committee shall— (1) advise on coordinating Federal activities to promote the inclusion of pregnant and lactating women in clinical research; (2) promote opportunities for Federal agencies and private actors to advance the inclusion of pregnant and lactating women in clinical research; (3) develop and annually update a summary of Federal agency progress toward implementing recommendations included in the September 2018 Report to the Secretary of Health and Human Services, and the August 2020 Report Implementation Plan to the Secretary of Health and Human Services, prepared by the Task Force on Research Specific to Pregnant Women and Lactating Women; (4) identify new recommendations for the Secretary regarding Federal activities to address gaps in knowledge and research regarding safe and effective therapies for pregnant and lactating women; and (5) receive updates on private sector and international efforts to include pregnant and lactating women in clinical research. (c) Membership (1) In general The Committee shall be composed of— (A) the Federal members listed in paragraph (2)